Injectable Drug Delivery Market is expected to reach $43.3 Billion by 2017

1
MarketsandMarkets Presents
Injectable Drug Delivery Market worth
43.3 Billion by 2017

http//www.marketsandmarkets.com/Market-Reports/in
jectable-drug-delivery-market-150.html
2
The Injectables Drug Delivery Market by
Formulations Liposomes, Microspheres,
Nanoparticles, Devices Disposables Reusable,
Fillable Prefilled, Pen, Needle Free Auto
Injectors Therapeutics Diabetes Oncology -
Global Forecasts to 2017,analyzes and studies the
major market drivers, restraints, and
opportunities in North America, Europe,
Asia-Pacific, and Rest of the World. Browse gtgt
155 data tables. 27
figures. in-depth TOC on
Injectables Drug Delivery Market 2017. 
http//www.marketsandmarkets.com/Market-Reports/
injectable-drug-delivery-market-150.html Early
buyers will receive 10 customization on this
report. Request to Download Free PDF
Brochure _at_ http//www.marketsandmarkets.com/pdfdow
nload.asp?id150
3
The global injectable drug delivery technologies
market was valued at 22.5 billion in 2012 it is
expected to reach 43.3 billion by 2017 at a CAGR
of 14.0 from 2012 to 2017. The injectable drug
delivery technologies market is broadly
categorized into two major segments, namely,
devices technologies and formulation
technologies. Based on product, the injectable
drug delivery devices technologies market is
further categorized into conventional injection
devices, self injection devices, and others
(microneedles, nanoneedles and blunt needle
injections), while injectable drug delivery
formulation technologies market is categorized
into conventional drug delivery formulations and
novel drug delivery formulations. Conventional
injection devices segment accounted for the
largest shareof the overall injectable drug
delivery technologies market in 2012. Hormonal
disorders commanded the largest share of 50.0 of
the global injectable drug delivery technologies
market in 2012 it is expected to grow at a CAGR
of 13.9 to reach 21.6 billion by 2017. However,
auto-immune diseases are the fastest growing
segment of this market due to the advent of
biologics (tumor necrosis factor (TNF) and
Interleukin 1 (IL-1)) and improving patient
compliance by the development of self injection
devices. Inquire Before Buying _at_
http//www.marketsandmarkets.com/Enquiry_Before_Bu
ying.asp?id150
4
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Bloghttp//twitter.com/market
smarkets
http//www.linkedin.com/company/marketsandmarkets
5
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/in
jectable-drug-delivery-market-150.html